非甾体抗炎药对COVID-19是敌是友?

IF 0.2 Q4 ANESTHESIOLOGY
Reham Mahrous, Amr Abdelnasser, Raghda Fouda, Mohamed Abd Al Moniem Morsy, Omnia Mandour
{"title":"非甾体抗炎药对COVID-19是敌是友?","authors":"Reham Mahrous, Amr Abdelnasser, Raghda Fouda, Mohamed Abd Al Moniem Morsy, Omnia Mandour","doi":"10.35975/apic.v27i1.2123","DOIUrl":null,"url":null,"abstract":"At the beginning of COVID-19 pandemic the use of NSAIDS was avoided. This was because the previous studies suggesting that NSAIDs may be associated with increased risk of complications of lower respiratory tract infections. Later on studies involved the patients who used NSAIDs for some chronic conditions and showed no additional harm among these patients. Then many studied assessed the benefit of using NSAIDs in COVID-19 patients for management of pain and fever and showed no additional risk among these patients.
 Key words: COVID-19; pandemic; NSAIDs
 Citation: Mahrous R, Abdelnasser A, Fouda R, Morsy MAAM, Mandour O. NSAIDs in COVID-19, friend or foe? Anaesth. pain intensive care 2022;27(1):119−122; DOI: 10.35975/apic.v27i1.2123
 Received: May 29, 2022; Reviewed: June 28, 2022; Accepted: July 03, 2022","PeriodicalId":7735,"journal":{"name":"Anaesthesia, Pain & Intensive Care","volume":null,"pages":null},"PeriodicalIF":0.2000,"publicationDate":"2023-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"NSAIDs in COVID-19, friend or foe?\",\"authors\":\"Reham Mahrous, Amr Abdelnasser, Raghda Fouda, Mohamed Abd Al Moniem Morsy, Omnia Mandour\",\"doi\":\"10.35975/apic.v27i1.2123\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"At the beginning of COVID-19 pandemic the use of NSAIDS was avoided. This was because the previous studies suggesting that NSAIDs may be associated with increased risk of complications of lower respiratory tract infections. Later on studies involved the patients who used NSAIDs for some chronic conditions and showed no additional harm among these patients. Then many studied assessed the benefit of using NSAIDs in COVID-19 patients for management of pain and fever and showed no additional risk among these patients.
 Key words: COVID-19; pandemic; NSAIDs
 Citation: Mahrous R, Abdelnasser A, Fouda R, Morsy MAAM, Mandour O. NSAIDs in COVID-19, friend or foe? Anaesth. pain intensive care 2022;27(1):119−122; DOI: 10.35975/apic.v27i1.2123
 Received: May 29, 2022; Reviewed: June 28, 2022; Accepted: July 03, 2022\",\"PeriodicalId\":7735,\"journal\":{\"name\":\"Anaesthesia, Pain & Intensive Care\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.2000,\"publicationDate\":\"2023-01-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Anaesthesia, Pain & Intensive Care\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.35975/apic.v27i1.2123\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"ANESTHESIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Anaesthesia, Pain & Intensive Care","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.35975/apic.v27i1.2123","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ANESTHESIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

在COVID-19大流行开始时,避免使用非甾体抗炎药。这是因为先前的研究表明,非甾体抗炎药可能与下呼吸道感染并发症的风险增加有关。后来的研究涉及使用非甾体抗炎药治疗某些慢性疾病的患者,并没有显示这些患者有额外的危害。随后,许多研究评估了在COVID-19患者中使用非甾体抗炎药治疗疼痛和发烧的益处,并显示这些患者没有额外的风险。 关键词:COVID-19;大流行;非甾体抗炎药# x0D;引用本文:Mahrous R, Abdelnasser A, Fouda R, Morsy MAAM, Mandour O. nsaid在COVID-19中的作用:是敌是友?Anaesth。疼痛重症监护2022;27(1):119−122;DOI: 10.35975 / apic.v27i1.2123& # x0D;收稿日期:2022年5月29日;审核时间:2022年6月28日;录用日期:2022年7月3日
本文章由计算机程序翻译,如有差异,请以英文原文为准。
NSAIDs in COVID-19, friend or foe?
At the beginning of COVID-19 pandemic the use of NSAIDS was avoided. This was because the previous studies suggesting that NSAIDs may be associated with increased risk of complications of lower respiratory tract infections. Later on studies involved the patients who used NSAIDs for some chronic conditions and showed no additional harm among these patients. Then many studied assessed the benefit of using NSAIDs in COVID-19 patients for management of pain and fever and showed no additional risk among these patients. Key words: COVID-19; pandemic; NSAIDs Citation: Mahrous R, Abdelnasser A, Fouda R, Morsy MAAM, Mandour O. NSAIDs in COVID-19, friend or foe? Anaesth. pain intensive care 2022;27(1):119−122; DOI: 10.35975/apic.v27i1.2123 Received: May 29, 2022; Reviewed: June 28, 2022; Accepted: July 03, 2022
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
0.40
自引率
0.00%
发文量
56
审稿时长
4 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信